The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome

Digestive Diseases and Sciences

Volumn 55, Issue 5, 2010, Pages 1385-1390

  Merat, Shahin ^a   Khalili, Shadi ^a   Mostajabi, Pardise ^a   Ghorbani, Anahita ^a   Ansari, Reza ^a   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Abdominal pain; Delayed action preparations; Irritable bowel syndrome; Peppermint oil

Indexed keywords

PEPPERMINT OIL; PLACEBO; VEGETABLE OIL;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; APPETITE; ARTICLE; BLINDNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG COATING; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RELEASE; DRUG SAFETY; FEMALE; HEARTBURN; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SIDE EFFECT; SYMPTOM; XEROSTOMIA; CHI SQUARE DISTRIBUTION; DELAYED RELEASE FORMULATION; NONPARAMETRIC TEST; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; CHI-SQUARE DISTRIBUTION; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; PLACEBOS; PLANT OILS; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 77953626749     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0854-9     Document Type: Article

References (28)

1. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut. 1999;45(2):II43-II47.
2. Foxx-Orenstein A. IBS-review and what's new. MedGenMed. 2006;8:20.
3. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology. 1995;109:1736-1741. doi:10.1016/0016-5085(95)90738-6.
4. Martin R, Barron JJ, Zacker C. Irritable bowel syndrome: Toward a cost-effective management approach. Am J Manag Care. 2001;7:S268-S275.
5. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654-660. doi:10.1053/gast. 2000.16484.
6. Dean BB, Aguilar D, Barghout V, et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care. 2005;11:S17-S26.
7. Hadley SK, Gaarder SM. Treatment of irritable bowel syndrome. American Family Physician. 2005;72:2501-2506.
8. Kligler B, Chaudhary S. Peppermint oil. American Family Physician. 2007;75:1027-1030.
9. Gobel H, Fresenius J, Heinze A, Dworschak M, Soyka D. Effectiveness of oleum menthae piperitae and paracetamol in therapy of headache of the tension type. Nervenarzt. 1996;67: 672-681. doi:10.1007/s001150050040.
10. May B, Kuntz HD, Kieser M, Kohler S. Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia. Arzneimittel-Forschung. 1996;46:1149-1153.
11. Sparks MJ, O'Sullivan P, Herrington AA, Morcos SK. Does peppermint oil relieve spasm during barium enema? British Journal of Radiology. 1995;68:841-843.
12. Asao T, Kuwano H, Ide M, et al. Spasmolytic effect of peppermint oil in barium during double-contrast barium enema compared with Buscopan. Clinical Radiology. 2003;58:301-305. doi: 10.1016/S0009-9260(02)00532-9. (Pubitemid 36416972)
13. Schuhmacher A, Reichling J, Schnitzler P. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro. Phytomedicine. 2003;10:504-510. doi: 10.1078/094471103322331467. (Pubitemid 37092674)
14. Hills JM, Aaronson PI. The mechanism of action of peppermint oil on gastrointestinal smooth muscle. An analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and guinea pig. Gastroenterology. 1991;101:55-65.
15. Hawthorn M, Ferrante J, Luchowski E, Rutledge A, Wei XY, Triggle DJ. The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations. Alimentary Pharmacology & Therapeutics. 1988;2:101-118.
16. Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008; 337:a2313. doi:10.1136/bmj.a2313.
17. Rees WD, Evans BK, Rhodes J. Treating irritable bowel syndrome with peppermint oil. BMJ. 1979;2:835-836. doi:10.1136/bmj.2.6194.835.
18. Grigoleit HG, Grigoleit P. Peppermint oil in irritable bowel syndrome. Phytomedicine. 2005;12:601-606. doi:10.1016/j.phymed.2004.10.005. (Pubitemid 40943537)
19. Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L. Peppermint oil (mintoil) in the treatment of irritable bowel syndrome: a prospective double-blind placebo-controlled randomized trial. Dig Liver Dis. 2007;39:530-536. doi:10.1016/j.dld.2007.02.006. (Pubitemid 46746646)
20. Vahedi H, Merat S, Momtahen S, et al. Clinical trial: The effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 2008;27:678-684.
21. Liu JH, Chen GH, Yeh HZ, Huang CK, Poon SK. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. Journal of Gastroenterology. 1997;32:765-768. doi:10.1007/BF02936952.
22. Motamed N, Ayatollahi AR, Zare N, Sadeghi-Hassanabadi A. Validity and reliability of the Persian translation of the SF-36 version 2 questionnaire. East Mediterr Health J. 2005;11: 349-357.
23. Bertram S, Kurland M, Lydick E, Locke GR 3rd, Yawn BP. The patient's perspective of irritable bowel syndrome. Journal of Family Practice. 2001;50:521-525.
24. Grigoleit HG, Grigoleit P. Pharmacology and preclinical pharmacokinetics of peppermint oil. Phytomedicine. 2005;12:612-616. doi:10.1016/j.phymed.2004.10. 007. (Pubitemid 40943539)
25. Amouretti M, Le Pen C, Gaudin AF, et al. Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterologie Clinique et Biologique. 2006;30:241-246. doi: 10.1016/S0399-8320(06)73160-8.
26. Cain KC, Headstrom P, Jarrett ME, et al. Abdominal pain impacts quality of life in women with irritable bowel syndrome. American Journal of Gastroenterology. 2006;101:124-132. doi: 10.1111/j.1572-0241.2006.00404.x. (Pubitemid 43381719)
27. Bond B, Quinlan J, Dukes GE, Mearin F, Clouse RE, Alpers DH. Irritable bowel syndrome: more than abdominal pain and bowel habit abnormalities. Clin Gastroenterol Hepatol. 2009;7:73-79. doi:10.1016/j.cgh.2008.08.011.
28. Montori VM, Guyatt GH. Intention-to-treat principle. CMAJ. 2001;165:1339-1341.